Potassium Phosphate, Tribasic → 4-(6-Methoxy-pyridin-3-yl)-2-morpholin-4-yl-7-pyridin-3-yl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine
反応式
Cl[C:2]1[C:3]2[CH2:16][CH2:15][N:14]([C:17]3[CH:18]=[N:19][CH:20]=[CH:21][CH:22]=3)[C:4]=2[N:5]=[C:6]([N:8]2[CH2:13][CH2:12][O:11][CH2:10][CH2:9]2)[N:7]=1.[CH3:23][O:24][C:25]1[CH:30]=[CH:29][C:28](B2OC(C)(C)C(C)(C)O2)=[CH:27][N:26]=1.COC1C=CC=C(OC)C=1C1C=CC=CC=1P(C1CCCCC1)C1CCCCC1.P([O-])([O-])([O-])=O.[K+].[K+].[K+]>C([O-])(=O)C.[Pd+2].C([O-])(=O)C.CN(C)C=O>[CH3:23][O:24][C:25]1[N:26]=[CH:27][C:28]([C:2]2[C:3]3[CH2:16][CH2:15][N:14]([C:17]4[CH:18]=[N:19][CH:20]=[CH:21][CH:22]=4)[C:4]=3[N:5]=[C:6]([N:8]3[CH2:13][CH2:12][O:11][CH2:10][CH2:9]3)[N:7]=2)=[CH:29][CH:30]=1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 2
反応条件
- 温度
- 100 °C
実験手順
To 4-chloro-2-morpholin-4-yl-7-pyridin-3-yl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine (20 mg, 0.0629 mmol), 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (29.6 mg, 0.126 mmol), palladium acetate (1.4 mg, 0.00630 mmol), S-Phos (5.2 mg, 0.0126 mmol) and potassium phosphate (26.7 mg, 0.126 mmol), dimethylformamide (1 ml) was added, followed by being degassed under ultrasonic irradiation. This was stirred at 100° C. for 3 hours, followed by extraction with ethyl acetate with the addition of water, and the organic layer was washed with brine. After drying over anhydrous sodium sulfate, concentration was carried out under reduced pressure, followed by elution with 2M ammonia methanol solution through SCX resin and then concentration.
後処理
- customby being degassed under ultrasonic irradiation
- extractionfollowed by extraction with ethyl acetate with the addition of water
- washthe organic layer was washed with brine
- dry with materialAfter drying over anhydrous sodium sulfate, concentration
- washfollowed by elution with 2M ammonia methanol solution through SCX resin
- concentrationconcentration
出典と根拠
- ORDレコード
- ord-2ed38285a4634155a2bdc6c798b15dfe
- 出典データセット
- uspto-grants-2011_09
- 特許番号
- US08022205B2
反応ノート
読み込み中…